On this page
Bosentan
Active ingredient 6 prescription 7 with labelling
Overview
Source: NDC DirectoryIngredient name
BOSENTAN
Base moiety
BOSENTAN
RxNorm CUI
UNII
Q326023R30
Medication products
8
Brand names
3
Dosage forms
5
FAERS reports
50,110 · not a risk measure
- Bosentan Powder
- Bosentan Monohydrate Powder
- Tracleer bosentan · Tablet, for Suspension
- Bosentan Tablet, Film Coated
- Bosentan Tablet, Coated
- bosentan Tablet, for Suspension
- Bosentan Tablet
- Tracleer bosentan · Tablet, Film Coated
Entries without a link are products listed by the FDA that carry no approval record, therapeutic equivalence rating or official labelling, so they have no detail page. Their facts are shown inline.
By dosage form
| Dosage form | Products | Examples |
|---|---|---|
| Powder | 2 | Bosentan, Bosentan Monohydrate |
| TABLET, For Suspension | 2 | Tracleer, bosentan |
| TABLET, Film Coated | 2 | Bosentan, Tracleer |
| TABLET, Coated | 1 | Bosentan |
| Tablet | 1 | Bosentan |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Ingredient name, strengths, products, labelers, packages |
| DailyMed RxNorm mappings | NLM | RxNorm concept identifier (RxCUI) |
| FAERS | FDA | Adverse event report totals |